Summary
Since cyclosporin A (CsA) is an immuno-suppressive agent, its beneficial effect in psoriasis suggests that immune cells may play a role in the pathogenesis and resolution of psoriasis. To determine early effects of CsA in psoriasis, we quantitated immune cells using double immunofluorescence microscopy on biopsy specimens obtained prior to therapy and after 3,7, and 14 days of CsA therapy. CsA therapy resulted in significant reductions in the absolute number of immune cells (including T cells, monocytes/macrophages, and antigen presenting cells) contained within psoriatic skin. The effect was rapid, with over one-half of the reduction in the density of HLe1+ (human leukocyte antigen-1 positive or bone marrow derived) cells, including T cells, activated T cells, monocytes, and Langerhans cells (LCs), occurring within 3 days. Despite the overall reduction in the numbers of immunocytes in the skin, the proportion of T cells, Langerhans cells, and monocytes in relation to the total number of immune cells was unchanged with therapy, reflecting equally proportional losses of each subtype. Dermal CD1+DR+ cells (putative Langerhans cells), which are not found in normal skin but are present in lesional psoriasis skin, were virtually cleared from the papillary dermis after CsA therapy. Although absolute numbers of epidermal Langerhans cells, defined as cells expressing both CD1 (T6) and DR molecules (CD1+DR+), were also reduced after CsA, epidermal non-Langerhans CD1-DR+ cells (macrophages, activated T cells, DR- keratinocytes) demonstrated a proportionally greater decrease, with the ratio of CD1+DR+ Langerhans cells/non-Langerhans CD1-DR+ epidermal cells changing from a mean of 0.82 at baseline to 1.92 at day 14. Thus, early in the course of therapy, CsA appears to be effective at clearing CD1-DR+ cells while leaving LC relatively intact in the epidermis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ellis CN, Gorsulowsky DC, Hamilton TA, Billings JK, Brown MD, Headington JT, Cooper KD, Baadsgaard O, Duell EA, Annesley TM, Turcotte JG, Voorhees JJ (1986) Cyclosporine improves psoriasis in a double-blind study. J Am Med Assoc 256:3110–3116
Baker BS, Griffiths CEM, Lambert S, Powles AV, Leonard JN, Valdimarsson H, Fry L (1987) The effects of cyclosporin A on T lymphocyte and dendritic cell sub-population in psoriasis. Br J Dermatol 116:503–510
de Jong MCJM, Blanken R, Nanninga J, Van Voorst Vader PC, Poppema S (1986) Defined in situ enumeration of T6 and HLA-DR expressing epidermal Langerhans cells: morphologic and methodologic aspects. J Invest Dermatol 87:698–702
Andrew W, Andrew NV (1949) Lymphocytes in the normal epidermis of the rat and of man. Anat Rec 104:217–242
Cooper KD, Breathnach SM, Caughman SW, Palini AG, Waxdal MJ, Katz SI (1985) Fluorescence microscopic and flow cytometric analysis of bone marrow-deprived cells in human epidermis: a search for the human analogue of the murine dendritic Thy-1+ epidermal cell. J Invest Dermatol 85:546–552
Morhenn VB, Mahrle G (1981) Expression of HLA-DR antigen on skin cells in psoriatic plaques. Clin Res 29: 608A
Stingl G, Katz SI, Clement L, Green I, Shevach EM (1978) Immunologic functions of Ia-bearing epidermal Langerhans cells. J Immunol 121:2005–2013
Baadsgaard O, Gupta A, Ellis CN, Voorhees JJ, Cooper KD (1989) Psoriasis epidermal cells demonstrate increased numbers and function of non-Langerhans cell antigen presenting cells. J Invest Dermatol 92:190–195
Poulter LW, Seymour GJ, Duke O, Janossy G, Panayi G (1982) Immunohistochemical analysis of delayed-type hypersensitivity in man. Cell Immunol 74:358–369
Bos JD, Zoneveld I, Das PK, Krieg SR, van der Loos CM, Kapsenberg ML (1987) The skin immune system (SIS): distribution and immunophenotype of lymphocyte subpopulators in normal human skin. J Invest Dermatol 88:569–573
Bjerke JR (1982) In situ characterization and counting of mononuclear cells in lesions of different clinical forms of psoriasis. Acta Dermatol Venereol (Stockh) 62:93–100
Bjerke JR, Krogh TK, Matre (1978) Characterization of mononuclear cell infiltrates in psoriatic lesions. J Invest Dermatol 71:340–343
Baker BS, Swain AF, Griffiths CEM, Leonard JN, Fry L, Valdimarsson H (1985) The effects to topical treatment with steroids or dithranol on epidermal T lymphocytes and dendritic cells in psoriasis. Scand J Immunol 22:471–477
Ashworth J, Turbitt ML, Mackie R (1986) The distribution and quantification of the epidermis. Clin Exp Dermatol 11:153–158
Haftek M, Faure M, Schmitt D, Thivolet J (1983) Langerhans cells in skin from patients with psoriasis: quantitative and qualitative study of T6 and HLA-DR antigen-expressing cells and changes with aromatic retinoid administration. J Invest Dermatol 81:10–14
Lisi P (1973) Investigation on Langerhans cells in pathological human epidermis. Acta Derm Venereol (Stockh) 53:425–428
Baker BS, Swain AF, Fry L, Valdimarsson H (1984) Epidermal T lymphocytes and HLA-DR expression in psoriasis. Br J Dermatol 110:555–564
Morhenn VB, Abel EA, Mahrle G (1982) Expression of HLA-DR antigen in skin from patients with psoriasis. J Invest Dermatol 78:165–168
Bos JD, Hulsebosch HJ, Krieg SR, Bakker PM, Cormane RH (1983) Immunocompetent cells in psoriasis. Arch Dermatol Res 275:181–189
Harrist TJ, Mahlbauer JE, Murphy GF, Mihm MC, Bhan AK (1983) T6 is superior to Ia (HLA-DR) as a marker for Langerhans cells and indeterminate cells in normal epidermis: a monoclonal antibody study. J Invest Dermatol 80:100–103
Horton JJ, Allen MH, MacDonald DM (1986) An assessment of Langerhans cell quantification in tissue section. J Am Acad Dermatol 11:591–593
Bos JD, van Garderen ID, Krieg SR, Poulter LW (1986) Different in situ distribution patterns of dendritic cells having Langerhans (T6+) and interdigitating (RFD1+) cell immunophenotype in psoriasis, atopic dermatitis, and other inflammatory dermatoses. J Invest Dermatol 87:358–361
Alegre VA, Mac Donald DM, Poulter LW (1986) The simultaneous presence of Langerhans cell and interdigitating cell antigenic markers on inflammatory dendritic cells. Clin Exp Immunol 64:330–333
Marks JG Jr, Zaino RJ, Bressler MF, Williams JV (1987) Changes in lymphocyte and Langerhans cell populations in allergic and irritant contact dermatitis. Int J Dermatol 26:354–357
Jimbow K, Chiba M, Horikoshi T (1982) Electron microscopic identification of Langerhans cells in the dermal infiltrates of mycosis fungoides. J Invest Dermatol 78:102
Cooper KD, Fox P, Neises GR, Katz SI (1985) Effects of ultraviolet radiation on human epidermal cell alloantigen presentation: Initial depression of Langerhans cell dependent function is followed by the appearance of T6-DR+ cells that enhance epidermal alloantigen presentation. J Immunol 134:129–137
Cooper KD, Neises GR, Katz SI (1986) Antigen presenting OKM5+ melanophages appear in human epidermis after ultraviolet radiation. J Invest Dermatol 86:363–370
Baadsgaard O, Wulf HC, Wantzin GL, Cooper KD: UVB and UVC, but not UVA, potently induce the appearance of T6-DR+ antigen-presenting cells in the human epidermis. J Invest Dermatol 89: 113–118
Baadsgaard O, Fox DA, Cooper KD (1988) Human epidermal cells from ultraviolet light-exposed skin preferentially activate autoreactive CD4+2H4+ suppressor-induced lymphocytes and CD8+ suppressor/cytotoxic lymphocytes. J Immunol 140:1738–1744
Schopf RE, Jung HM, Morsches B, Bork K (1986) Stimulation of T cells by autologous mononuclear leukocytes and epidermal cells in psoriasis. Arch Dermatol Res 279:89–94
Cooper KD, Baadsgaard O, Gupta A, Billings J, Brown M, Ellis C, Voorhees JJ (1987) Phenotype and function of cyclosporin A-sensitive epidermal immunocompetent cells in psoriasis. Clin Res 35:387A
Gottlieb AB, Lifshitz B, Fu SM, Staino-Coico L, Wang CY, Carter DM (1986) Expression of HLA-DR molecules by keratinocytes, and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaques. J Exp Med 164:1013–1028
Author information
Authors and Affiliations
Additional information
This work was supported in part by the Babcock Foundation
Rights and permissions
About this article
Cite this article
Gupta, A.K., Baadsgaard, O., Ellis, C.N. et al. Lymphocytes and macrophages of the epidermis and dermis in lesional psoriatic skin, but not epidermal Langerhans cells, are depleted by treatment with cyclosporin A. Arch Dermatol Res 281, 219–226 (1989). https://doi.org/10.1007/BF00431054
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00431054